Communiqués Comera Life Sciences Holdings, Inc.

Actions

CMRA

US20037C1080

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 18:13:16 24/09/2026			Varia. 5j.	Varia. 1 janv.
0,000100 ^USD	+9 900,00%		-.--%	+9 900,00%

31/07	Comera Life Sciences Holdings, Inc. annonce la nomination de Janice Marie McCourt au poste de Chief Business Officer	CI
30/01/24	Comera Life Sciences Holdings, Inc. annonce des changements au niveau de son directeur général	CI

Communiqués

04/01/24	Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option	AQ
06/12/23	Comera Life Sciences Announces Process Exploring Strategic Alternatives	GL
13/11/23	Comera Life Sciences Appoints Dorothy Clarke to Board of Directors	AQ
13/11/23	Comera Life Sciences Appoints Dorothy Clarke to Board of Directors	GL
09/11/23	Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights	AQ
16/10/23	Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference	GL
12/09/23	Comera Life Sciences Announces the Completion of $4.1 Million Private Placement	AQ
16/08/23	Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities	GL
10/08/23	Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights	AQ
08/08/23	Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform	GL
01/08/23	Comera Life Sciences Announces $4.1 Million Private Placement	AQ
20/07/23	Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients	GL
20/07/23	Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients	AQ
19/05/23	COMERA LIFE SCIENCES HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
12/05/23	COMERA LIFE SCIENCES HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)	AQ
11/05/23	Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights	AQ
05/05/23	COMERA LIFE SCIENCES HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
27/04/23	Comera Life Sciences to Participate in Four Upcoming Conferences	AQ
27/04/23	Comera Life Sciences to Participate in Four Upcoming Conferences	GL
03/04/23	Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology	GL
03/04/23	Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology	GL
24/03/23	COMERA LIFE SCIENCES HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
17/03/23	COMERA LIFE SCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
16/03/23	Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights	AQ
21/02/23	COMERA LIFE SCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)	AQ